Total Voting Rights

Summary by AI BETAClose X

CVS Group plc has announced that as of 29 May 2026, its total issued share capital comprises 70,022,712 ordinary shares of 0.2p each, following the cancellation of shares purchased under its recent buyback program. This updated figure will serve as the denominator for shareholders calculating their notification obligations under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

CVS Group plc
29 May 2026
 

29 May 2026

 

CVS Group plc

("CVS" or the "Company")

Total Voting Rights

CVS, the UK listed veterinary group and a leading provider of veterinary services, announces that, as of 29 May 2026, following cancellation of the Ordinary Shares purchased pursuant to the Company's share buyback programme (announced on 26 May 2026) prior to the date of this announcement, the Company's total issued share capital consists of 70,022,712 ordinary shares of 0.2p each ("Ordinary Shares").

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.


Contacts:

CVS Group plc

via FGS Global

Scott Morrison, Group General Counsel and Company Secretary




FGS Global

+44 (0)207 251 3801

Faeth Birch

cvsgroup@fgsglobal.com 

Charlie Chichester


 

 

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs 9,000 personnel, including 2,500 veterinary surgeons and 3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings